Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
+8.93%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$12.8B
AUM Growth
+$89.4M
(+0.71%)
Cap. Flow
-$657M
Cap. Flow
% of AUM
-5.15%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
2,833
New
113
Increased
921
Reduced
935
Closed
132
Top Buys
| 1 |
Linde
LIN
|
+$10.8M |
| 2 |
Tesla
TSLA
|
+$7.91M |
| 3 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
+$7.03M |
| 4 |
Verizon
VZ
|
+$6.99M |
| 5 |
GE HealthCare
GEHC
|
+$6.42M |
Top Sells
| 1 |
TSMC
TSM
|
+$87.9M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$69.9M |
| 3 |
ASML
ASML
|
+$49.2M |
| 4 |
Baidu
BIDU
|
+$28.5M |
| 5 |
Crown Castle
CCI
|
+$28.5M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Healthcare | 12.75% |
| 3 | Financials | 11.56% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Warby Parker
WRBY
$3.29B
| $125K | ﹤0.01% |
11,790
+9,678
| +458% | +$103K |
|
1427
Zurn Elkay Water Solutions
ZWS
$7.89B
| $125K | ﹤0.01% |
5,870
-30
| -0.5% | -$639 |
|
|
RXDX
1428
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $125K | ﹤0.01% |
1,166
+910
| +355% | +$97.6K |
|
1429
Option Care Health
OPCH
$4.77B
| $124K | ﹤0.01% |
3,914
+45
| +1% | +$1.43K |
|
1430
Provident Bancorp
PVBC
$226M
| $124K | ﹤0.01% |
18,067
+19
| +0.1% | +$130 |
|
1431
Teladoc Health
TDOC
$1.35B
| $124K | ﹤0.01% |
4,800
+110
| +2% | +$2.84K |
|
1432
MACOM Technology Solutions
MTSI
$9.74B
| $123K | ﹤0.01% |
1,731
-260
| -13% | -$18.5K |
|
1433
Weatherford International
WFRD
$4.56B
| $123K | ﹤0.01% |
2,066
-780
| -27% | -$46.4K |
|
1434
Coca-Cola Consolidated
COKE
$10.7B
| $122K | ﹤0.01% |
2,280
-4,650
| -67% | -$249K |
|
1435
Hilton Grand Vacations
HGV
$4.03B
| $122K | ﹤0.01% |
2,736
-380
| -12% | -$16.9K |
|
1436
iRhythm Technologies
IRTC
$5.82B
| $122K | ﹤0.01% |
984
-29
| -3% | -$3.6K |
|
1437
Agilysys
AGYS
$3.01B
| $121K | ﹤0.01% |
1,465
-50
| -3% | -$4.13K |
|
1438
Select Medical
SEM
$1.58B
| $121K | ﹤0.01% |
8,666
-1,913
| -18% | -$26.7K |
|
1439
Supernus Pharmaceuticals
SUPN
$2.58B
| $121K | ﹤0.01% |
3,335
-90
| -3% | -$3.27K |
|
1440
Dakota Gold
DC
$539M
| $120K | ﹤0.01% |
33,164
+21,364
| +181% | +$77.3K |
|
|
PRFT
1441
DELISTED
Perficient Inc
PRFT
| $120K | ﹤0.01% |
1,660
| – | – |
|
1442
Herc Holdings
HRI
$4.21B
| $119K | ﹤0.01% |
1,047
| – | – |
|
1443
Macy's
M
$4.58B
| $119K | ﹤0.01% |
6,803
-121,500
| -95% | -$2.13M |
|
1444
G-III Apparel Group
GIII
$1.13B
| $118K | ﹤0.01% |
7,600
-850
| -10% | -$13.2K |
|
1445
Aaon
AAON
$6.7B
| $117K | ﹤0.01% |
1,815
+150
| +9% | +$9.67K |
|
1446
Corcept Therapeutics
CORT
$7.87B
| $117K | ﹤0.01% |
5,380
-3,230
| -38% | -$70.2K |
|
1447
Marathon Digital Holdings
MARA
$5.92B
| $116K | ﹤0.01% |
13,304
+7,004
| +111% | +$61.1K |
|
1448
Renasant Corp
RNST
$3.61B
| $115K | ﹤0.01% |
3,745
| – | – |
|
1449
Taylor Morrison
TMHC
$6.96B
| $115K | ﹤0.01% |
3,016
| – | – |
|
1450
NCR Voyix
VYX
$1.76B
| $115K | ﹤0.01% |
7,951
+815
| +11% | +$11.8K |
|